Mediwound Ltd. buy dimontalban
Start price
13.08.22
/
50%
€1.97
Target price
13.08.23
€14.00
Performance (%)
1.02%
End price
22.08.22
€1.99
Summary
This prediction ended on 22.08.22 with a price of €1.99. The BUY prediction by dimontalban finished with a performance of 1.02%. dimontalban has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Mediwound Ltd. | 3.846% | 3.846% | 63.636% |
| iShares Core DAX® | 2.594% | -1.158% | 14.782% |
| iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% |
| iShares Nikkei 225® | 0.687% | -8.354% | 18.454% |
| iShares S&P 500 | 2.209% | -0.942% | 31.361% |
According to dimontalban what are the pros and cons of Mediwound Ltd. for the foreseeable future?
Pros
Very Future proof/growth oriented business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Good rating
High Investments for future growth
ROE higher than 10% per year
Capable Management
Very good company culture
Leading role in innovation
Some uniques
Differentiated customer and product portfolio
Growths faster than the competition
Sustainability is important
Top 10 in its market
Known brand
Cons
Very low/no dividend yield expected
negative Cash Flow expected
High risks in the balance sheet
Increased challenges to pay loans and raise capital
high free float
High risks for its business
Significant cyclical dependencies